Lee Ainslie - Maverick Capital
Holding/activity history for Charles River Laboratories International, Inc. (CRL)
← All CRL superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 8,178 | 0.02 | Buy | 0.02 | $146.33–228.88 · VW $183.88i | $1,410,705 | SEC |
| 2021 Q3 | 0 | 0.00 | Sell 100.00% | 0.01 | $368.43–460.21 · VW $419.59i | SEC | |
| 2021 Q2 | 1,536 | 0.01 | Reduce 68.65% | <0.01 | $290.31–372.51 · VW $336.17i | $568,000 | SEC |
| 2021 Q1 | 4,899 | 0.01 | Buy | 0.01 | $243.37–303.79 · VW $276.42i | $1,420,000 | SEC |
| 2020 Q4 | 0 | 0.00 | Sell 100.00% | <0.01 | $219.79–257.88 · VW $238.54i | SEC | |
| 2020 Q3 | 1,162 | <0.01 | Buy | <0.01 | $174.82–228.86 · VW $207.53i | $263,000 | SEC |
Price snapshot:
Current price$229.75
Avg. buy price$172.50
+/- since buy33.19%
52-week low$144.26
52-week high$237.86